Clinical Trial Update: This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is [Phase 2]

View source ↗

Summary

Phase 2 trial assessing tolerability and efficacy of BI 730357 in patients with plaque psoriasis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• BI 730357

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2022-06-02